HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunological analysis in familial common variable immunodeficiency.

Abstract
Immunological and genetic studies were performed in nine members from three generations of the family of a patient with common variable immunodeficiency (CVI). Two additional symptomatic members (mother and grandmother) had CVI. Among other six asymptomatic members, two had CVI and one had selective IgA deficiency. The proportions of monoclonal antibody defined total T cells (Leu 1+), helper phenotype (Leu 3+) suppressor phenotype (Leu 2+) T cells, natural killer cells (Leu 7+) and surface Ig+ B cells and proliferative response to phytohaemagglutinin (PHA), concanavalin A (Con A), pokeweed mitogen (PWM) and in mixed lymphocyte reaction (MLR) were comparable to controls. Addition of purified interleukin-2 (IL-2) resulted in augmentation of PHA-induced proliferation of T lymphocytes similar to that seen in the controls, however with IL-2 freshly isolated T cells in the absence of PHA demonstrated markedly increased proliferative response, suggesting the presence of in vivo activated T cells. Study of HLA phenotype did not reveal any linkage. This study demonstrates the genetic nature, possibly autosomal dominant inheritance, of common variable immunodeficiency; however the immunodeficiency is not linked to any specific HLA antigen.
AuthorsH B Fuchs, L Slater, H Novey, K Ong, S Gupta
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 56 Issue 1 Pg. 29-33 (Apr 1984) ISSN: 0009-9104 [Print] England
PMID6609034 (Publication Type: Case Reports, Journal Article)
Chemical References
  • HLA Antigens
  • Interleukin-2
Topics
  • Adolescent
  • Adult
  • Child
  • Diseases in Twins
  • Female
  • HLA Antigens (analysis)
  • Humans
  • IgA Deficiency
  • Immunologic Deficiency Syndromes (genetics, immunology)
  • Interleukin-2
  • Leukocyte Count
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Pedigree
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: